About this trial
Bern Intracoronary Optical Coherence Tomography and Coronary Computed Tomography Angiography Registry (BIOCORE) is a systematic institutional registry on patients undergoing paired CCTA and OCT for validation and development of advanced methods to determine coronary plaque morphology, lesion severity, PCI guidance, and it association with long-term clinical outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
≥18 years of age
Written informed consent
CCTA within 3 months from invasive coronary angiography and OCT
At least one vessel with ≥50% diameter stenosis on CCTA
Disqualifiers
CCTA performed more than 3 months from OCT
Poor OCT quality
Poor CCTA quality
Coronary anomalies
Trial population
Patients undergoing CCTA and invasive coronary angiography with OCT in native coronary vessels within 3 months
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Diagnostic accuracy in plaque phenotyping CCTA vs. OCT
Proportion of correctly classified plaques quantitative computed tomography (QCT) (low-attenuation, non-calcified, calcified plaques) against the gold standard OCT (lipid-rich, fibrous, fibro-calcific plaque)
PCI planning with CCTA vs. gold standard OCT
Diagnostic accuracy of CCTA in identifying the need for PCI and agreement in stent sizing
Photon-counting vs. conventional CCTA
Proportion of correctly classified plaques with photon-counting CCTA vs. conventional CCTA (low-attenuation, non-calcified, calcified plaques) against the gold standard OCT for plaque morphology (lipid-rich, fibrous, fibro-calcific plaque)
Other outcomes
Clinical outcomes throughout 1 and 5 years
* All-cause death * Cardiovascular death * Myocardial infarction * Unstable angina pectoris * Clinically-driven coronary revascularization * Stent thrombosis * In-stent-restenosis
Sponsors and contacts
Click on the lead sponsor to view all of their trials.